How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

4,186 results for

Counseling in HIV Infection

by
...
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

141. Recipient Assessment for Transplantation - HIV, HBV and HCV infection

Recipient Assessment for Transplantation - HIV, HBV and HCV infection ________________________________________________________________________________________________________________________ Recipient Assessment for Transplantation March 2013 Page 1 of 23 HIV, HBV and HCV infection Date written: November 2011 Author: David Gracey GUIDELINES a. Human immunodeficiency virus (HIV) We recommend that HIV infection should not preclude a patient from being assessed for kidney transplantation (Level 1D (...) ) b. Hepatitis B virus (HBV) We recommend that HBV infection should not preclude a patient from being assessed for kidney transplantation (Level 1D) c. Hepatitis C virus (HCV) We recommend that HCV infection should not preclude a patient from being assessed for kidney transplantation (Level 1D) UNGRADED SUGGESTIONS FOR CLINICAL CARE HIV Testing for HIV should be performed in all potential kidney transplant candidates (ungraded) Assessment of HIV-infected potential kidney transplant patients should

2013 KHA-CARI Guidelines

142. March 2014 supplement to the 2013 consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection

for treating and preventing HIV infection, Chapter 5 – HIV diagnosis and ARV drugs for HIV prevention Key messages • HIV self-testing has the potential to increase the number of people living with HIV who have access to testing, know their status, are diagnosed and initiate treatment. • HIV self-testing shares many characteristics with current HIV testing and counselling approaches, including products, accuracy issues, linkage to care, potential benefits and risks and regulatory policies and frameworks (...) and preventing HIV infection. Chapter 5, “HIV diagnosis and ARV drugs for HIV prevention” summarizes diverse models of HIV testing and counselling services to increase access to HIV diagnosis that are presented in more detail in the WHO 2012 strategic HIV testing and counselling policy framework. This technical update was prepared in November 2013 through the collaboration of the WHO, UNAIDS and key experts. Its primary objectives are to synthesize experiences, research and policies on HIV self-testing so

2014 World Health Organisation HIV Guidelines

143. Sero-prevalence and associated risk factors for hepatitis C virus infection among voluntary counseling testing and anti retroviral treatment clinic attendants in Adwa hospital, northern Ethiopia (PubMed)

Sero-prevalence and associated risk factors for hepatitis C virus infection among voluntary counseling testing and anti retroviral treatment clinic attendants in Adwa hospital, northern Ethiopia Hepatitis C virus (HCV) is a major health concern where about 3% of the world's population is infected globally. In Ethiopia the prevalence ranges from 0.9 to 1.3% in the general populations. Human immune deficiency virus (HIV) patients due to their weak immune response are heavily affected by the virus (...) . There is no data on magnitude and associated risk factors for HCV infection among voluntary counseling, testing center and anti retroviral treatment clinic Attendants in the study area. Therefore, the aim of this study was to determine the sero-prevalence and associated risk factors for HCV infection among voluntary counseling testing and anti retroviral treatment clinic attendants Adwa general hospital.Cross sectional study was carried out among 302 participants (151 HIV-negative from VCT and 151 HIV-positive

Full Text available with Trip Pro

2016 BMC research notes

144. Boosting ART uptake and retention among HIV-infected pregnant and breastfeeding women and their infants: the promise of innovative service delivery models. (PubMed)

Boosting ART uptake and retention among HIV-infected pregnant and breastfeeding women and their infants: the promise of innovative service delivery models. With the rapid scale-up of antiretroviral treatment (ART) in the "Treat All" era, there has been increasing emphasis on using differentiated models of HIV service delivery. The gaps within the clinical cascade for mothers and their infants suggest that current service delivery models are not meeting families' needs and prompt re (...) -consideration of how services are provided. This article will explore considerations for differentiated care and encourage the ongoing increase of ART coverage through innovative strategies while also addressing the unique needs of mothers and infants.Service delivery models should recognize that the timing of the mother's HIV diagnosis is a critical aspect of determining eligibility. Women newly diagnosed with HIV require a more intensive approach so that adequate counselling and monitoring of ART

Full Text available with Trip Pro

2018 Journal of the International AIDS Society

145. mHealth Physical Activity Trial for Older HIV-infected Adults (mFIT)

mHealth Physical Activity Trial for Older HIV-infected Adults (mFIT) mHealth Physical Activity Trial for Older HIV-infected Adults (mFIT) - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. mHealth Physical (...) Activity Trial for Older HIV-infected Adults (mFIT) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT03708640 Recruitment Status : Enrolling by invitation First Posted : October 17, 2018 Last Update Posted : December 4, 2018 Sponsor: Johns Hopkins University Collaborator: National Institute of Allergy

2018 Clinical Trials

146. Long-Acting Cabotegravir Plus VRC01LS for Viral Suppression in HIV-1-Infected Adults

Long-Acting Cabotegravir Plus VRC01LS for Viral Suppression in HIV-1-Infected Adults Long-Acting Cabotegravir Plus VRC01LS for Viral Suppression in Adults Living With HIV-1 - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies (...) (VRC01LS), in adults living with HIV-1 with suppressed plasma viremia. Condition or disease Intervention/treatment Phase HIV Infections Drug: Oral Cabotegravir (CAB) Drug: Nucleoside Reverse Transcriptase Inhibitors (NRTIs) Drug: Long-Acting Injectable Cabotegravir (CAB LA) Biological: VRC01LS Drug: Standard of Care (SOC) Oral ART Phase 2 Detailed Description: This study will assess the safety, tolerability, pharmacokinetics, and antiviral activity of long-acting cabotegravir (CAB LA) plus the broadly

2018 Clinical Trials

147. Loss to follow-up and mortality among HIV-infected adolescents receiving antiretroviral therapy in Pune, India. (PubMed)

Loss to follow-up and mortality among HIV-infected adolescents receiving antiretroviral therapy in Pune, India. India has the highest number of HIV-infected adolescents in Asia, but little is known about their treatment outcomes. We assessed rates and factors associated with loss to follow-up (LTFU) and mortality among Indian adolescents.The analysis included adolescents (10-19 years old) starting antiretroviral therapy (ART) between 2005 and 2014 at BJ Government Medical College, Pune, India (...) with mortality.A third of adolescents had been lost to follow-up or died by follow-up year 6. Older age was a risk factor for LTFU and advanced clinical disease for death. Strategies to improve retention counselling for older adolescents and closer clinical monitoring of all adolescents must be considered.© 2018 British HIV Association.

2018 HIV medicine

148. Hepatitis B & C virus infection in HIV seropositive individuals & their association with risk factors: A hospital-based study (PubMed)

Hepatitis B & C virus infection in HIV seropositive individuals & their association with risk factors: A hospital-based study Hepatitis B and hepatitis C virus (HBV and HCV) cause acute and chronic hepatitis, and infections with HBV and HCV are common in HIV-infected patients. The present study was conducted to determine the co-infection of hepatitis B and C virus in stored serum samples of HIV-positive/negative individuals attending an Integrated Counselling and Testing Centre (ICTC) in north (...) India and their association with certain risk factors.This study included a total of 840 serum samples, of which 440 were from HIV seropositive individuals and 400 were from control individuals seeking voluntary check-up of HIV status at ICTC. Serum samples were used for the detection of HBV and HCV infection.HBV infection (11%) was found to be less in contrast to HCV (13%) amongst the HIV seropositive. In controls, HBV and HCV infection was two and three per cent, respectively. Co-infection of HBV

Full Text available with Trip Pro

2018 The Indian journal of medical research

149. Phase 4 Comparative Trial of Benzathine Penicillin G for Treatment of Early Syphilis in Subjects With or Without HIV Infection

Phase 4 Comparative Trial of Benzathine Penicillin G for Treatment of Early Syphilis in Subjects With or Without HIV Infection Phase 4 Comparative Trial of Benzathine Penicillin G for Treatment of Early Syphilis in Subjects With or Without HIV Infection - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached (...) the maximum number of saved studies (100). Please remove one or more studies before adding more. Phase 4 Comparative Trial of Benzathine Penicillin G for Treatment of Early Syphilis in Subjects With or Without HIV Infection The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care provider before participating. Read our

2018 Clinical Trials

150. Evaluating Long-Acting Antiretroviral Therapy in Non-Adherent HIV-Infected Individuals

Evaluating Long-Acting Antiretroviral Therapy in Non-Adherent HIV-Infected Individuals The LATITUDE Study: Long-Acting Therapy to Improve Treatment SUccess in Daily LifE - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before (...) , 2018 Last Update Posted : March 19, 2019 See Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) Information provided by (Responsible Party): National Institute of Allergy and Infectious Diseases (NIAID) Study Details Study Description Go to Brief Summary: The purpose of this study is to compare the efficacy, safety, and durability of two different strategies to treat participants with a history of sub-optimal adherence and control of their HIV infection: long-acting (LA

2018 Clinical Trials

151. More Options for Children and Adolescents (MOCHA): Oral and Long-Acting Injectable Cabotegravir and Rilpivirine in HIV-Infected Children and Adolescents

More Options for Children and Adolescents (MOCHA): Oral and Long-Acting Injectable Cabotegravir and Rilpivirine in HIV-Infected Children and Adolescents More Options for Children and Adolescents (MOCHA): Oral and Long-Acting Injectable Cabotegravir and Rilpivirine in HIV-Infected Children and Adolescents - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail (...) Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. More Options for Children and Adolescents (MOCHA): Oral and Long-Acting Injectable Cabotegravir and Rilpivirine in HIV-Infected Children and Adolescents (MOCHA) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal

2018 Clinical Trials

152. Safety and Efficacy of Dolutegravir/Lamivudine (DTG/3TC) in Therapy-naive Human Immunodeficiency Virus-1 (HIV-1) Infected Adolescents

Safety and Efficacy of Dolutegravir/Lamivudine (DTG/3TC) in Therapy-naive Human Immunodeficiency Virus-1 (HIV-1) Infected Adolescents Safety and Efficacy of Dolutegravir/Lamivudine (DTG/3TC) in Therapy-naive Human Immunodeficiency Virus-1 (HIV-1) Infected Adolescents - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You (...) have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Safety and Efficacy of Dolutegravir/Lamivudine (DTG/3TC) in Therapy-naive Human Immunodeficiency Virus-1 (HIV-1) Infected Adolescents The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care provider before

2018 Clinical Trials

153. Positive Virological Outcomes of HIV-Infected Patients on Protease Inhibitor-Based Second-Line Regimen in Cambodia: The ANRS 12276 2PICAM Study (PubMed)

: NCT01801618) is a cross-sectional study of HIV-infected adults on PR inhibitor-based second-line regimen since at least 6 months, conducted in 13 representative sites, comprising more than 90% of the target population. Adults with HIV RNA above 250 copies/mL (threshold of the assay) at inclusion received boosted adherence counseling during 3 months followed by HIV RNA control. For confirmed virological failure, genotype resistance test was performed and expert committee used results for therapeutic (...) Positive Virological Outcomes of HIV-Infected Patients on Protease Inhibitor-Based Second-Line Regimen in Cambodia: The ANRS 12276 2PICAM Study Assessment of virological outcomes among HIV-infected patients receiving protease (PR) inhibitor-based second-line regimen are uncommon in Cambodia. The objective of this study is to assess the virological effectiveness of this regimen as well as impact of adherence boosting for patients experiencing virological failure.The 2PICAM study (Clinicaltrial

Full Text available with Trip Pro

2018 Frontiers in public health

154. Capturing Changes in HIV-Infected Breastfeeding Mothers’ Cognitive Processes from Before Delivery to 5 Months Postpartum: An Application of the Pile-Sorting Technique in Haiti (PubMed)

Capturing Changes in HIV-Infected Breastfeeding Mothers’ Cognitive Processes from Before Delivery to 5 Months Postpartum: An Application of the Pile-Sorting Technique in Haiti The cognitive processes involved in individuals' perceptions and prioritization of information, and how these change with experience or exposure to interventions, are rarely examined in the evaluation of nutrition interventions. Exclusive breastfeeding counseling is a common infant and young-child feeding intervention (...) and is used to promote HIV-free survival in the prevention of mother-to-child transmission programs. However, it is often designed without adequate attention to the changes in mothers' perceptions over the course of their early breastfeeding experiences.The aim of this study was to identify HIV-infected breastfeeding mothers' cognitive structure (their organization of messages and ideas) of infant feeding messages and to characterize whether their cognitive organization of infant feeding messages changed

Full Text available with Trip Pro

2018 Current Developments in Nutrition

155. Retention outcomes and drivers of loss among HIV-exposed and infected infants in Uganda: a retrospective cohort study. (PubMed)

Retention outcomes and drivers of loss among HIV-exposed and infected infants in Uganda: a retrospective cohort study. Uganda's HIV Early Infant Diagnosis (EID) program rapidly scaled up testing of HIV-exposed infants (HEI) in its early years. However, little was known about retention outcomes of HEI after testing. Provision of transport refunds to HEI caregivers was piloted at 3 hospitals to improve retention. This study was conducted to quantify retention outcomes of tested HEI, identify (...) HIV+ infants, only 40% (98/244) received results and enrolled at an ART Clinic. Of enrolled HIV+ infants, only 43% (57/98) were still active in chronic care. 36% (27/75) of eligible HIV+ infants started ART. Our analysis identified 6 categories of factors driving HEI loss-to-follow-up: fragmentation of EID services across several clinics, with most poorly equipped for HEI care/follow-up; poor referral mechanisms and data management systems; inconsistent clinical care; substandard counseling; poor

Full Text available with Trip Pro

2018 BMC Infectious Diseases

156. Readiness for Antiretroviral Therapy: Implications for Linking HIV-Infected Individuals to Care and Treatment (PubMed)

Readiness for Antiretroviral Therapy: Implications for Linking HIV-Infected Individuals to Care and Treatment Using survey data collected immediately after referral for ART (N = 87), this study examined ART-readiness among individuals (18 years and older) attending a mobile health clinic in South Africa. Most participants reported being very ready (84%) and motivated (85%) to start ART, but only 72% were assessed as ready for ART on all measures. Treatment readiness was lower among individuals (...) who did not think they would test HIV-positive (aOR 0.26, p < 0.05) and among individuals who reported being in good health (aOR 0.44, p < 0.1). In contrast, higher readiness was associated with better ART knowledge (aOR 4.31, p < 0.05) and knowing someone who had experienced positive health effects from ART (aOR 2.65, p < 0.05). Results indicate that post-test counselling will need to be designed to deal with surprise at HIV diagnosis, and that health messaging needs to be carefully crafted

Full Text available with Trip Pro

2018 AIDS and behavior

157. Ocular surface squamous neoplasia in HIV-infected patients: current perspectives (PubMed)

, and no significant trend has been discovered between CD4 count and grade of OSSN. Furthermore, the effect of highly active antiretroviral therapy on OSSN is controversial. The current recommendation is to conduct HIV screening in all cases presenting with OSSN to rule out undiagnosed HIV infection. Patient counseling is crucial, with emphasis on regular follow-up to address high recurrence rates and early presentation to an ophthalmologist for of any symptoms in the unaffected eye. Effective evidence-based (...) Ocular surface squamous neoplasia in HIV-infected patients: current perspectives Ocular surface squamous neoplasia (OSSN) refers to a spectrum of conjunctival and corneal epithelial tumors including dysplasia, carcinoma in situ, and invasive carcinoma. In this article, we discuss the current perspectives of OSSN associated with HIV infection, focusing mainly on the epidemiology, pathophysiology, clinical manifestations, diagnosis, and treatment of these tumors in patients with HIV. Upsurge

Full Text available with Trip Pro

2018 HIV/AIDS (Auckland, N.Z.)

158. Retention of HIV infected pregnant and breastfeeding women on option B+ in Gomba District, Uganda: a retrospective cohort study. (PubMed)

Retention of HIV infected pregnant and breastfeeding women on option B+ in Gomba District, Uganda: a retrospective cohort study. Lifelong antiretroviral therapy for HIV infected pregnant and lactating women (Option B+) has been rapidly scaled up but there are concerns about poor retention of women initiating treatment. However, facility-based data could underestimate retention in the absence of measures to account for self-transfers to other facilities. We assessed retention-in-care among women (...) their status to their partners, aHR = 1.59 (95% CI: 1.16-2.19) were more likely to be LTFU. Facilitators for Option B+ retention based on qualitative findings were adequate counselling, disclosure, and the desire to stay alive and raise HIV-free children. Drug side effects, inadequate counselling, stigma, and unsupportive spouses, were barriers to retention in care.Retention under Option B+ is suboptimal and is under-estimated at health facility level. There is need to institute mechanisms for tracking

Full Text available with Trip Pro

2018 BMC Infectious Diseases

159. Quality of life in HIV-infected Chinese women and their family caregivers: an intervention study. (PubMed)

Quality of life in HIV-infected Chinese women and their family caregivers: an intervention study. China is experiencing a rapid increase in the number of HIV-infected women. In this study, we describe the development and preliminary evaluation of an intervention tailored for Chinese HIV-infected women and caregivers to improve their self- and family management, with goals of enhancing their physical quality of life (QOL) and decreasing their depressive symptomatology. Forty-one HIV-infected (...) Linear Modeling was used to evaluate the efficacy of the intervention. Chinese HIV-infected women in the intervention arm had significantly higher probability of higher physical QOL at month 1 and lower probability of clinically meaningful depressive symptomatology at month 3 compared with women in the control arm. In contrast, the effects of the intervention were less salient for caregivers. This study represents one of the first in China to include family caregivers in HIV management. Feasibility

Full Text available with Trip Pro

2018 AIDS care Controlled trial quality: uncertain

160. The effect of a 12-week combinational exercise program on CD4 count and mental health among HIV infected women: A randomized control trial. (PubMed)

The effect of a 12-week combinational exercise program on CD4 count and mental health among HIV infected women: A randomized control trial. There are conflicting results regarding the effects of exercise on immune function of HIV positive patients. Exercise can also be beneficial to psychological functioning of the patients. The purpose of this study was to determine the impact of a 12-week aerobic and resistance exercise training program on mental health and CD4 counts among female HIV (...) + patients.This clinical trial was conducted between September and December 2013. Forty participants (women age range 20-40) were carefully selected from 240 HIV-positive women referred to Voluntary Counseling and Treatment Center (VCT) and randomly assigned to either exercise (80 min of aerobic and strength training while receiving the VCT's routine services) group (n = 20) or control (received the VCT's routine services only) group (n = 20). To assess their mental health status, all participants completed

Full Text available with Trip Pro

2018 Journal of exercise science and fitness Controlled trial quality: uncertain

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>